Medicine Active substance Licence holder Status
Betnesol 0.1% w/v Eye, Ear and Nasal Drops, solution PA1638/001/001
BETAMETHASONE SODIUM PHOSPHATE
RPH Pharmaceuticals AB Marketed
Betnesol-N 0.1% w/v, 3500 IU/ml Eye, Ear and Nasal Drops, solution PA1638/002/001
Neomycin sulfate, BETAMETHASONE SODIUM PHOSPHATE
RPH Pharmaceuticals AB Marketed
Bettamousse 1 mg/g (0.1%) cutaneous foam PA1638/009/001
Betamethasone valerate
RPH Pharmaceuticals AB Marketed
Cocois Ointment, coal tar 12.0% sulphur for external use 4.0%, salicylic acid 2.0% PA1638/005/001
Coal tar solution, Sulphur for external use, Salicylic acid
RPH Pharmaceuticals AB Marketed
Neo-Cytamen 1000 micrograms/ml Solution for Injection PA1638/004/001
Hydroxocobalamin
RPH Pharmaceuticals AB Marketed
Trandate 100mg Film-Coated Tablets PA1638/006/002
Labetalol hydrochloride
RPH Pharmaceuticals AB Marketed
Trandate 200mg Film-coated Tablets PA1638/006/003
Labetalol hydrochloride
RPH Pharmaceuticals AB Marketed
Trandate 5 mg/ml Solution for Injection PA1638/006/001
Labetalol hydrochloride
RPH Pharmaceuticals AB Marketed
Cite this database
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).
Copy citation
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.